UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ImaRx Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
86-0974730 |
|
|
|
(State of incorporation or organization)
|
|
(I.R.S. Employer
Identification No.) |
|
|
|
1635 East 18th Street, Tucson, AZ
|
|
85719 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered
|
|
Name of each exchange on which
each class is to be registered |
|
|
|
Common Stock, par value $0.0001 per share
|
|
The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the
Exchange Act and is effective pursuant to General Instruction A.(c), please check the following
box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the
Exchange Act and is effective pursuant to General Instruction A.(d), please check the following
box. o
Securities Act registration statement file number to which the form relates: 333-142646
Securities to be registered pursuant to Section 12(g) of the Act: None.
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrants Securities to be Registered.
A description of the securities to be registered hereunder is contained in the section
entitled Description of Capital Stock, included in the Registrants Form S-1 Registration
Statement, as amended (File No. 333-142646), filed under the Securities Act of 1933, as amended,
with the Securities Exchange Commission. Such portion of the Registration Statement is incorporated
herein by reference
Item 2. Exhibits.
Not applicable.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the
registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
|
|
|
|
|
|
IMARX THERAPEUTICS, INC.
|
|
Date: July 11, 2007 |
By: |
/s/
Bradford A. Zakes |
|
|
|
Bradford A. Zakes |
|
|
|
President and Chief Executive Officer |
|
|